Literature DB >> 9306909

Seroprevalence of hepatitis B markers among female and transsexual sex workers in Athens, Greece.

A Tsakris, K P Kyriakis, S Chryssou, G Papoutsakis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9306909      PMCID： PMC1195830          DOI： 10.1136/sti.73.3.223-a

Source DB:  PubMed          Journal:  Genitourin Med        ISSN： 0266-4348


× No keyword cloud information.
  6 in total

1.  Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis delta virus infection in female prostitutes in the United States.

Authors:  L Rosenblum; W Darrow; J Witte; J Cohen; J French; P S Gill; J Potterat; K Sikes; R Reich; S Hadler
Journal:  JAMA       Date:  1992-05-13       Impact factor: 56.272

2.  Control of sexually transmitted diseases today and tomorrow.

Authors:  R S Morton
Journal:  Genitourin Med       Date:  1987-06

3.  The prevalence of sexually transmitted diseases among prostitutes in Malaysia.

Authors:  S Ramachandran; Y F Ngeow
Journal:  Genitourin Med       Date:  1990-10

4.  Influence of syphilis in hepatitis B transmission in a cohort of female prostitutes.

Authors:  M A Bratòs; J M Eiros; A Orduña; M Cuervo; R Ortiz de Lejarazu; A Almaraz; J F Martín-Rodríguez; M P Gutiérrez-Rodríguez; E Orduña Prieto; A Rodríguez-Torres
Journal:  Sex Transm Dis       Date:  1993 Sep-Oct       Impact factor: 2.830

5.  Hepatitis B serology in Greek prostitutes: significance of the different serum markers.

Authors:  E Kaklamani; A Kyriakidou; D Trichopoulos; G Papoutsakis; I Koumandaki; D Karalis
Journal:  J Hyg (Lond)       Date:  1980-04

6.  Prevalence of hepatitis B antigen and antibody in prostitutes.

Authors:  G Papaevangelou; D Trichopoulos; T Kremastinou; G Papoutsakis
Journal:  Br Med J       Date:  1974-05-04
  6 in total
  1 in total

1.  New data concerning the epidemiology of Hepatitis B virus infection in Greece.

Authors:  Konstantinos D Pantazis; Ioannis S Elefsiniotis; Hero Brokalaki
Journal:  Gastroenterol Res Pract       Date:  2008       Impact factor: 2.260
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.